Index-Linked Products: The Illusion of Safety in a Real Inflation Storm
Let’s get blunt about index-linked products,
You get sold the promise: index-linked products as a straightforward inflation shield. Reality checks hit hard when liquidity dries up or tracking error balloons. In 2022, several Canadian pension funds learned the lesson the hard way—what looked like protection became a source of drag and exposure. The myth is comfort; the reality is discomfort when markets get rough.
You can’t ignore how fee structures quietly erode any benefit. Every basis point matters, especially when inflation spikes. Canadian regulatory filings and post-mortem studies from the 2020–2022 period reveal that institutions who relied too heavily on these products suffered unnecessary slippage and performance gaps.
Consensus loves a simple story, but the evidence refuses to cooperate. When stress tests replace sales pitches, cracks in index-linked products become obvious. Are you asking enough about underlying mechanics and what happens in a true liquidity crunch? The only thing worse than risk is pretending it isn’t there.
On your side, always,
P.S. Results may vary. Past performance doesn’t guarantee future outcomes.